DK0937041T3 - Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel - Google Patents

Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel

Info

Publication number
DK0937041T3
DK0937041T3 DK97911049T DK97911049T DK0937041T3 DK 0937041 T3 DK0937041 T3 DK 0937041T3 DK 97911049 T DK97911049 T DK 97911049T DK 97911049 T DK97911049 T DK 97911049T DK 0937041 T3 DK0937041 T3 DK 0937041T3
Authority
DK
Denmark
Prior art keywords
hydroxyphenylacetyl
pyrrolidinium
oxyl
cyclopentyl
dimethyl
Prior art date
Application number
DK97911049T
Other languages
Danish (da)
English (en)
Inventor
Christian R Noe
Ernst Mutschler
Guenter Lambrecht
Michael Elgert
Sittah Czeche
Magali Waelbroeck
Original Assignee
Christian R Noe
Ernst Mutschler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian R Noe, Ernst Mutschler filed Critical Christian R Noe
Application granted granted Critical
Publication of DK0937041T3 publication Critical patent/DK0937041T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK97911049T 1996-11-11 1997-11-11 Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel DK0937041T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT197396 1996-11-11
PCT/AT1997/000245 WO1998021183A1 (de) 1996-11-11 1997-11-11 Enantiomerenreine, basische aryl-cycloalkyl-hydroxycarbonsäureester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
DK0937041T3 true DK0937041T3 (da) 2003-08-11

Family

ID=3525062

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97911049T DK0937041T3 (da) 1996-11-11 1997-11-11 Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel
DK03005232.8T DK1371645T3 (da) 1996-11-11 1997-11-11 Anvendelse af (3S,2'R)-glycopyrronium som lægemiddel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03005232.8T DK1371645T3 (da) 1996-11-11 1997-11-11 Anvendelse af (3S,2'R)-glycopyrronium som lægemiddel

Country Status (19)

Country Link
US (1) US6307060B1 (pt)
EP (3) EP0937041B1 (pt)
JP (1) JP2001504459A (pt)
CN (1) CN100391942C (pt)
AT (1) ATE238280T1 (pt)
AU (1) AU745331B2 (pt)
CA (1) CA2271276C (pt)
DE (1) DE59709927D1 (pt)
DK (2) DK0937041T3 (pt)
ES (2) ES2407135T3 (pt)
HK (1) HK1061023A1 (pt)
HU (1) HU228273B1 (pt)
NO (1) NO314354B1 (pt)
NZ (1) NZ336202A (pt)
PL (1) PL195520B1 (pt)
PT (2) PT1371645E (pt)
RU (1) RU2238936C2 (pt)
SI (2) SI1371645T1 (pt)
WO (1) WO1998021183A1 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613795B2 (en) 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
DK0937041T3 (da) * 1996-11-11 2003-08-11 Christian R Noe Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
EP1302458A4 (en) 2000-07-11 2005-10-19 Banyu Pharma Co Ltd ESTERDERIVATE
ES2206021B1 (es) 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
AT412088B (de) * 2002-12-18 2004-09-27 Pharmacon Forschung & Beratung Gmbh Verfahren zur herstellung der r,r oder s,s konfigurierten glycopyrronium-isomere
AU2002347552A1 (en) * 2002-12-23 2004-07-14 Ranbaxy Laboratories Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
DE60313898T2 (de) * 2003-04-10 2008-01-17 Ranbaxy Laboratories, Ltd. Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
PE20050231A1 (es) * 2003-06-24 2005-05-20 Novartis Ag Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3
SI1718336T1 (sl) 2004-02-06 2008-10-31 Meda Pharma Gmbh & Co Kg Nova kombinacija antiholinergika in beta mimetikov za zdravljenje respiratornih bolezni
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
JP2008504341A (ja) * 2004-06-29 2008-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドと抗コリン作用剤とを含む吸入用薬剤
EP1616567A1 (en) * 2004-07-16 2006-01-18 Boehringer Ingelheim Pharma GmbH & Co.KG Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
EP1781607A2 (en) * 2004-08-19 2007-05-09 Ranbaxy Laboratories Limited Pyrrolidine derivatives as muscarinic receptor antagonists
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428416D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0504463D0 (en) * 2005-03-03 2005-04-13 Arakis Ltd Method of crystallisation and purification
SI1863476T1 (sl) * 2005-03-16 2016-05-31 Meda Pharma Gmbh & Co. Kg Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni
TW200722418A (en) * 2005-04-20 2007-06-16 Astrazeneca Ab Novel compounds
WO2006114379A1 (de) * 2005-04-23 2006-11-02 Boehringer Ingelheim International Gmbh Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
CA2632780C (en) * 2005-12-21 2013-11-12 Meda Pharma Gmbh & Co. Kg Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases
GB0613161D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
EA017627B1 (ru) 2008-05-13 2013-01-30 Астразенека Аб Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора
AU2010253776B2 (en) * 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
KR101781237B1 (ko) 2010-01-28 2017-09-22 테론 파마슈티칼즈, 인크. 7-아조니아바이시클로〔2.2.1〕헵탄 유도체, 제조 방법, 및 그의 제약적 용도
AR081889A1 (es) * 2010-06-14 2012-10-24 Chiesi Farma Spa Forma cristalina de cloruro de glicopirronio
BR112012029824A2 (pt) * 2010-06-14 2016-08-09 Chiesi Farma Spa métodos para o preparo de cloreto de glicopirrônio, cloreto de glicopirrônio, composição farmacêutica e uso de cloreto de glicopirrônio
JOP20120023B1 (ar) 2011-02-04 2022-03-14 Novartis Ag صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
CN102627595A (zh) * 2012-03-09 2012-08-08 徐奎 一种制备格隆溴铵的方法
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US9452139B2 (en) 2013-03-14 2016-09-27 Novartis Ag Respirable agglomerates of porous carrier particles and micronized drug
AU2014229361B2 (en) 2013-03-14 2016-08-04 Novartis Ag Deamorphization of spray-dried formulations via spray-blending
CN104586841A (zh) * 2013-10-30 2015-05-06 中国药科大学 (3r,2’r)-格隆溴铵作为m3毒蕈碱性受体拮抗剂在制药中的用途
US9926270B2 (en) 2014-08-20 2018-03-27 Dermira, Inc. Process for production of glycopyrronium tosylate
ES2700597T3 (es) * 2014-12-24 2019-02-18 Lesvi Laboratorios Sl Proceso para la preparación de (3RS) -3 - [(2SR) - (2-ciclopentil-2-hidroxi-2-fenilacetil) oxi] -1,1-dimetilpirrolidinio
CN107304178B (zh) * 2016-04-21 2020-03-27 辽宁药联制药有限公司 一种毒蕈碱受体拮抗剂格隆溴铵手性对映体的制备方法
JP7161466B2 (ja) 2016-08-02 2022-10-26 ジャーニー メディカル コーポレーション グリコピロニウム化合物を作製するための方法及び使用する方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157671A (en) * 1964-11-17 Ljl-diethyl-a-hydroxypyrrolidimum
CA625276A (en) * 1961-08-08 D. Lunsford Carl Esters of amino alcohols
US2882276A (en) * 1959-04-14 Certain esters of amino alcohols
US2980693A (en) * 1961-04-18 Methods for producing same
CA629039A (en) * 1961-10-10 A.H. Robins Company 1-substituted-3-pyrrolidyl benzilates
GB821436A (en) * 1956-02-22 1959-10-07 Parke Davis & Co 3-pyrrolidinyl benzilates
US2958028A (en) * 1957-11-01 1960-10-25 Collins Radio Co Remote control system
US2956062A (en) * 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
US3185702A (en) * 1959-03-16 1965-05-25 Lunsford Carl Dalton Basic esters of 3-aryl-3-pyrrolidinols
GB885430A (en) * 1960-08-17 1961-12-28 Loewe Opta Ag Arrangement for receiving stereophonic transmissions
GB1170831A (en) * 1967-02-01 1969-11-19 Robins Co Inc A H O-Substituted Pyrrolidinols and S-Substituted Thiopyrrolidinols and Processes for their Preparation
US3691198A (en) * 1970-12-21 1972-09-12 Cpc International Inc Synthesis of 1-substituted-3-halopyrrolidines
FI49713C (fi) * 1974-05-15 1975-09-10 Medica Pharma Co Ltd Terapeuttisesti tehokkaan erytro-1-metyyli-3-pyrrolidinyyli-alfa-syklo -pentyylimandelaattimetobromidin valmistusmenetelmä.
US4208423A (en) * 1978-11-24 1980-06-17 Syntex Inc. Anticholinergic bronchodilators
US4228171A (en) * 1979-03-05 1980-10-14 Syntex (U.S.A.) Inc. Antichlorinergic bronchodilators
US4721722A (en) * 1985-07-12 1988-01-26 United Pharmaceuticals, Inc. Anti-spasmodic agents containing quaternary nitrogen
KR19990008109A (ko) * 1995-04-28 1999-01-25 나가사까 겐지로 1,4-이치환 피페리딘 유도체
WO1998000133A1 (en) 1996-07-01 1998-01-08 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
EP0909172A4 (en) 1996-07-01 1999-06-09 Sepracor Inc METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMERIC ENRICHED (R, s) -GLYCOPYRROLATE
DK0937041T3 (da) * 1996-11-11 2003-08-11 Christian R Noe Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel
US6603808B1 (en) 1999-07-22 2003-08-05 Compaq Information Technologies Group, L.P. Dual mode phone line networking modem utilizing conventional telephone wiring

Also Published As

Publication number Publication date
US6307060B1 (en) 2001-10-23
CA2271276C (en) 2009-01-13
SI1371645T1 (sl) 2013-07-31
HUP9903791A2 (hu) 2000-03-28
DE59709927D1 (de) 2003-05-28
NO991056D0 (no) 1999-03-03
RU2238936C2 (ru) 2004-10-27
PT937041E (pt) 2003-09-30
HU228273B1 (en) 2013-02-28
NZ336202A (en) 2000-10-27
SI0937041T1 (en) 2003-10-31
DK1371645T3 (da) 2013-06-03
AU745331B2 (en) 2002-03-21
HK1061023A1 (pt) 2004-09-03
PT1371645E (pt) 2013-05-21
NO991056L (no) 1999-05-11
EP1371645A1 (de) 2003-12-17
HUP9903791A3 (en) 2001-10-29
ES2195121T3 (es) 2003-12-01
CN100391942C (zh) 2008-06-04
EP1369414A1 (de) 2003-12-10
AU4856097A (en) 1998-06-03
PL195520B1 (pl) 2007-09-28
CA2271276A1 (en) 1998-05-22
EP1371645B1 (de) 2013-02-20
CN1237159A (zh) 1999-12-01
JP2001504459A (ja) 2001-04-03
WO1998021183A1 (de) 1998-05-22
PL332595A1 (en) 1999-09-27
NO314354B1 (no) 2003-03-10
ES2407135T3 (es) 2013-06-11
EP0937041B1 (de) 2003-04-23
ATE238280T1 (de) 2003-05-15
EP0937041A1 (de) 1999-08-25

Similar Documents

Publication Publication Date Title
DK0937041T3 (da) Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel
CA2092794A1 (fr) Naphtylalkylamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GR3019012T3 (en) Therapeutic compositions for intranasal administration which include ketorolac TM.
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
AU4616893A (en) New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
DK0876388T3 (da) Tricykliske erythromycinderivater
NO942952L (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
DE69734678D1 (de) 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung
AU656674B2 (en) New thiochroman compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
AU1643592A (en) Novel compound and use of the same as medicine
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
MY133438A (en) Morpholinobenzamide salts
AU7381591A (en) Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3- hexenamide-containing preparation, stabilizing method therefor and drug stabilized thereby
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
WO1994016705A3 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
AU7586191A (en) Hydroxyproline derivative, a process for the preparation thereof and pharmaceutical compositions containing it